CNS Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
365
across all filing types
Latest filing
2025-05-14
Regulatory Filings
Country
US
United States of America
Listing
US
CNSP
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that develops anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company's primary focus is on glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. Its lead drug candidate, Berubicin, is an anthracycline designed to cross the blood-brain barrier, a significant challenge in treating CNS tumors. The company's technology aims to enable therapeutics to penetrate the brain and directly target tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2025-05-14 | English | |
| FORM 424B4 | 2025-05-14 | English | |
| Regulatory Filings 2025 | 2025-05-14 | English | |
| Regulatory Filings 2025 | 2025-05-12 | English | |
| Regulatory Filings 2025 | 2025-05-12 | English | |
| AMENDMENT NO. 1 TO FORM S-1 | 2025-05-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 13090976 | FORM 8-K | 2025-05-14 | English | ||
| 13090963 | FORM 424B4 | 2025-05-14 | English | ||
| 13090967 | Regulatory Filings 2025 | 2025-05-14 | English | ||
| 13090961 | Regulatory Filings 2025 | 2025-05-12 | English | ||
| 13090964 | Regulatory Filings 2025 | 2025-05-12 | English | ||
| 13090975 | AMENDMENT NO. 1 TO FORM S-1 | 2025-05-12 | English | ||
| 13090992 | AMENDMENT NO. 1 TO FORM 10-K | 2025-04-30 | English | ||
| 13090982 | Regulatory Filings 2025 | 2025-04-17 | English | ||
| 13090969 | Regulatory Filings 2025 | 2025-04-17 | English | ||
| 13090970 | Regulatory Filings 2025 | 2025-04-14 | English | ||
| 13091019 | Regulatory Filings 2025 | 2025-04-14 | English | ||
| 13090971 | FORM S-1 | 2025-04-14 | English | ||
| 13090972 | Regulatory Filings 2025 | 2025-04-11 | English | ||
| 13090978 | FORM 8-K | 2025-04-09 | English | ||
| 13090973 | Regulatory Filings 2025 | 2025-04-07 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CNS Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35399/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35399 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35399 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35399 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35399}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CNS Pharmaceuticals, Inc. (id: 35399)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.